Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target

…, T Xu, A Sampath, SP Lim, B Canard, SG Vasudevan - Antiviral research, 2008 - Elsevier
New treatments are urgently needed to combat the increasing number of dengue fever
cases in endemic countries as well as amongst a large number of travellers from non-endemic …

Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus

…, SP Lim, Z Yin, TH Keller, SG Vasudevan… - Nature structural & …, 2006 - nature.com
The replication of flaviviruses requires the correct processing of their polyprotein by the viral
NS3 protease (NS3pro). Essential for the activation of NS3pro is a 47-residue region of …

A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs

…, HY Xu, M Flamand, SG Vasudevan - The Journal of …, 2007 - academic.oup.com
Dengue fever is an emerging arboviral disease for which no vaccine or antiviral treatment
exists and that causes thousands of fatalities each year. To develop an in vivo test system for …

Non-nucleoside inhibitors of Zika virus RNA-dependent RNA polymerase

…, ST Tan, RW Bates, SG Vasudevan… - Journal of …, 2020 - Am Soc Microbiol
Zika virus (ZIKV) remains a potentially significant public health concern because it can
cause teratogenic effects, such as microcephaly in newborns and neurological disease, like …

The flavivirus NS2B–NS3 protease–helicase as a target for antiviral drug development

D Luo, SG Vasudevan, J Lescar - Antiviral research, 2015 - Elsevier
The flavivirus NS3 protein is associated with the endoplasmic reticulum membrane via its
close interaction with the central hydrophilic region of the NS2B integral membrane protein. …

[HTML][HTML] Update on dengue: epidemiology, virus evolution, antiviral drugs, and vaccine development

A Wilder-Smith, EE Ooi, SG Vasudevan… - … infectious disease reports, 2010 - Springer
Dengue virus is the most widespread geographically of the arboviruses and a major public
health threat in the tropics and subtropics. Scientific advances in recent years have provided …

Construction and characterization of a stable subgenomic dengue virus type 2 replicon system for antiviral compound and siRNA testing

…, YL Chen, SP Lim, A Davidson, SG Vasudevan - Antiviral research, 2007 - Elsevier
Self-replicating, non-infectious flavivirus subgenomic replicons have been broadly used in
the studies of trans-complementation, adaptive mutation, viral assembly and packaging in …

[BOOK][B] Dengue and dengue hemorrhagic fever

DJ Gubler, EE Ooi, S Vasudevan, J Farrar - 2014 - books.google.com
Continued geographic expansion of dengue viruses and their mosquito vectors has seen
the magnitude and frequency of epidemic dengue/dengue hemorrhagic fever (DF/DHF) …

Crystal structure of the dengue virus RNA-dependent RNA polymerase catalytic domain at 1.85-angstrom resolution

…, H Malet, MP Egloff, B Canard, SG Vasudevan… - Journal of …, 2007 - Am Soc Microbiol
Dengue fever, a neglected emerging disease for which no vaccine or antiviral agents exist
at present, is caused by dengue virus, a member of the Flavivirus genus, which includes …

[HTML][HTML] A cellular screening platform, stably expressing DENV2 NS5, defines a novel anti-DENV mechanism of action of Apigenin based on STAT2 activation

…, ML Barreca, G Manfroni, A Bresciani, SG Vasudevan… - Virology, 2023 - Elsevier
Type I interferon (IFN–I) evasion by Dengue virus (DENV) is key in DENV pathogenesis. The
non-structural protein 5 (NS5) antagonizes IFN-I response through the degradation of the …